Cargando…
The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients
Non-alcoholic fatty liver disease (NAFLD) and serum uric acid (SUA) levels are risk factors for developing cardiovascular disease (CVD). Additionally, previous studies have suggested that high SUA levels increase the risk of having NAFLD. However, no study has investigated the relationship between S...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834479/ https://www.ncbi.nlm.nih.gov/pubmed/35162067 http://dx.doi.org/10.3390/ijerph19031042 |
_version_ | 1784649197012647936 |
---|---|
author | Kim, Kiduk Kang, Kyoonho Sheol, Hyewon Shin, Jihae Sim, Youngseo Yang, Taehoon Hwang, Jeongwon Lee, Ju-Mi |
author_facet | Kim, Kiduk Kang, Kyoonho Sheol, Hyewon Shin, Jihae Sim, Youngseo Yang, Taehoon Hwang, Jeongwon Lee, Ju-Mi |
author_sort | Kim, Kiduk |
collection | PubMed |
description | Non-alcoholic fatty liver disease (NAFLD) and serum uric acid (SUA) levels are risk factors for developing cardiovascular disease (CVD). Additionally, previous studies have suggested that high SUA levels increase the risk of having NAFLD. However, no study has investigated the relationship between SUA and CVD risk in NAFLD. This study analyzed the relationship between SUA and CVD in NAFLD. Data for this study used the 2016–2018 Korean National Health and Nutrition Examination Survey, which represents the Korean population. A total of 11,160 NAFLD patients were included. Participants with hepatic steatosis index ≥ 30 were considered to have NAFLD. Ten-year CVD risk was estimated using an integer-based Framingham risk score. Estimated 10-year CVD risk ≥ 20% was considered high risk. Multiple logistic regression was conducted to calculate the odds ratios (ORs) associated with SUA level and CVD risk. High CVD risk OR increases by 1.31 (95% CI 1.26–1.37) times per 1 mg/dL of SUA. After adjustment, SUA still had an increased risk (OR 1.44; 95% CI 1.38–1.51) of CVD. Compared with the lowest SUA quartile group, the highest quartile group showed a significantly higher risk of having CVD before (OR 2.76; 95% CI 2.34–3.25) and after (OR 4.01; 95% CI 3.37–4.78) adjustment. SUA is independently associated with CVS risk in NAFLD. |
format | Online Article Text |
id | pubmed-8834479 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88344792022-02-12 The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients Kim, Kiduk Kang, Kyoonho Sheol, Hyewon Shin, Jihae Sim, Youngseo Yang, Taehoon Hwang, Jeongwon Lee, Ju-Mi Int J Environ Res Public Health Article Non-alcoholic fatty liver disease (NAFLD) and serum uric acid (SUA) levels are risk factors for developing cardiovascular disease (CVD). Additionally, previous studies have suggested that high SUA levels increase the risk of having NAFLD. However, no study has investigated the relationship between SUA and CVD risk in NAFLD. This study analyzed the relationship between SUA and CVD in NAFLD. Data for this study used the 2016–2018 Korean National Health and Nutrition Examination Survey, which represents the Korean population. A total of 11,160 NAFLD patients were included. Participants with hepatic steatosis index ≥ 30 were considered to have NAFLD. Ten-year CVD risk was estimated using an integer-based Framingham risk score. Estimated 10-year CVD risk ≥ 20% was considered high risk. Multiple logistic regression was conducted to calculate the odds ratios (ORs) associated with SUA level and CVD risk. High CVD risk OR increases by 1.31 (95% CI 1.26–1.37) times per 1 mg/dL of SUA. After adjustment, SUA still had an increased risk (OR 1.44; 95% CI 1.38–1.51) of CVD. Compared with the lowest SUA quartile group, the highest quartile group showed a significantly higher risk of having CVD before (OR 2.76; 95% CI 2.34–3.25) and after (OR 4.01; 95% CI 3.37–4.78) adjustment. SUA is independently associated with CVS risk in NAFLD. MDPI 2022-01-18 /pmc/articles/PMC8834479/ /pubmed/35162067 http://dx.doi.org/10.3390/ijerph19031042 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kim, Kiduk Kang, Kyoonho Sheol, Hyewon Shin, Jihae Sim, Youngseo Yang, Taehoon Hwang, Jeongwon Lee, Ju-Mi The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients |
title | The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients |
title_full | The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients |
title_fullStr | The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients |
title_full_unstemmed | The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients |
title_short | The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients |
title_sort | association between serum uric acid levels and 10-year cardiovascular disease risk in non-alcoholic fatty liver disease patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834479/ https://www.ncbi.nlm.nih.gov/pubmed/35162067 http://dx.doi.org/10.3390/ijerph19031042 |
work_keys_str_mv | AT kimkiduk theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients AT kangkyoonho theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients AT sheolhyewon theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients AT shinjihae theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients AT simyoungseo theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients AT yangtaehoon theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients AT hwangjeongwon theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients AT leejumi theassociationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients AT kimkiduk associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients AT kangkyoonho associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients AT sheolhyewon associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients AT shinjihae associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients AT simyoungseo associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients AT yangtaehoon associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients AT hwangjeongwon associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients AT leejumi associationbetweenserumuricacidlevelsand10yearcardiovasculardiseaseriskinnonalcoholicfattyliverdiseasepatients |